CAB-AXL-ADC

Drug identity checked against registry records

Also recorded as BA3011

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCNCT04681131BioAtla, Inc.Phase 2Completed2025-07-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.